HDX-MS at Waters Waters Corporation 1

Similar documents
Overview of Waters Solutions for Biopharmaceutical Analysis and Characterization

Sasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll

Biotherapeutic Non-Reduced Peptide Mapping

Exploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma

Proteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1

ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

Proteomics Training Kit

Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules

An Unbiased Approach to Increasing Proteome Coverage Using Ion Mobility with MS E

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI

High throughput analysis at microscale: performance of ionkey/ms with Xevo G2-XS QTof under rapid gradient conditions

High throughput analysis at microscale: performance of ionkey/ms with Xevo G2-XS QTof under rapid gradient conditions

UNIFI: an innovative enabling platform Ken Eglinton Nordic User Training, September 2013

Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method

Method Development of a 2D LC-HRMS Extraction and Detection Method for Organophosphorus Flame Retardants in Environmental Water Samples

2012 Waters Corporation 1

ENHANCED MS WITH THE TURN OF A KEY

Solutions Guide. MX Series II Modular Automation for Nano and Analytical Scale HPLC And Low Pressure Fluid Switching Applications

Michael J. Chalmers and Patrick R. Griffin

Development and evaluation of Nano-ESI coupled to a triple quadrupole mass spectrometer for quantitative proteomics research

Waters Solutions for DMPK and Biomarker Analysis. Waters User Meeting ASMS 2011 Denver, Colorado. Stephen McDonald

Hichrom Limited 1 The Markham Centre, Station Road, Theale, Reading, Berkshire, RG7 4PE, UK Tel: +44 (0) Fax: +44 (0)

A highly sensitive and robust 150 µm column to enable high-throughput proteomics

Developing Quantitative UPLC Assays with UV

Advances in HDX Techniques

Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D.

Illicit Drug Analysis in Urine Using 2D LC-MS/MS for Forensic Toxicology

Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass

Automatic Combination of Orthogonal Separation Modes for Multiple Components in Mixtures

Microflow LC-MS with the turn of a key

A Unique LC-MS Assay for Host Cell Proteins(HCPs) ) in Biologics

Sean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL RESULTS AND DISCUSSION

Method Development Considerations for Reversed-Phase Protein Separations

Rapid Peptide Mapping via Automated Integration of On-line Digestion, Separation and Mass Spectrometry for the Analysis of Therapeutic Proteins

Isotopic Resolution of Chromatographically Separated IdeS Subunits Using the X500B QTOF System

Charged Surface Hybrid C18 for High Resolution LC and LC/MS Peptide Separations

Application Note. Authors. Abstract. Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore, India

Improving Retention Time Precision and Chromatography of Early Eluting Peptides with Acetonitrile/Water Blends as Solvent B

Xevo G2-S QTof and TransOmics: A Multi-Omics System for the Differential LC/MS Analysis of Proteins, Metabolites, and Lipids

How discovery activities can influence metabolic profiling in the regulatory space? C. DELATOUR EBF, 25 th September 2015

Supplemental Materials. Manuscript Title: Enhanced Detection of Low-Abundance Host Cell Protein (HCP) Impurities in

Thermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development

: presented at ASMS 2015

New Approaches to Quantitative Proteomics Analysis

Characterization of a fusion protein under native and denaturing conditions with maxis II

Dried Blood Spot Analysis From The Clinic To The Laboratory

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Analysis of Monoclonal Antibody (mab) Using Agilent 1290 Infinity LC System Coupled to Agilent 6530 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF)

[ ACQUITY UPLC system ] Performance so strong it moved the industry forward

The CebE/MsiK Transporter is a Doorway to the Cellooligosaccharide-mediated. Pathogenicity

[ ACQUITY UPLC SYSTEM ] Performance so strong it moved the industry forward

Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation

of peptide mapping chemistries, 130Å or 300Å with tunable UV, photodiode array, or mass spectrometry

Hongwei Xie, Martin Gilar, and John C. Gebler Waters Corporation, Milford, MA, U.S.A. INTRODUCTION EXPERIMENTAL

A Highly Accurate Mass Profiling Approach to Protein Biomarker Discovery Using HPLC-Chip/ MS-Enabled ESI-TOF MS

Analysis of Intact Monoclonal Antibodies Using an M3 MicroLC with the TripleTOF 6600

CaptiveSpray nanobooster

Trastuzumab Glycan Batch-to-Batch Profiling using a UPLC/FLR/Mass Spectrometry Platform

Introduction. Benefits of the SWATH Acquisition Workflow for Metabolomics Applications

E f f ic i ent ly Com pa ring Bat c h e s o f a n Intac t Mono c lo na l A n t ibo dy using t h e

Rapidly Characterize Antibody- Drug Conjugates and Derive Drug-to-Antibody Ratios Using LC/MS

The Role of Chemistry Consumables in Biopharmaceutical Product Development

Tabisam Khan 1, David R. Little 1, Liyu Yang 2, Jiwen Chen 2, Parya Nouri 2, Samy Tadros 2, Patrick J. Rudewicz 2

Application Note. Authors. Abstract. Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore India

EASY-Spray Columns. Guidance for column set up and installation Tips to maximize column lifetime

Next Generation Technology for Reproducible and Precise Proteome Profiling

Nano LC at 20 nl/min Made Easy: A Splitless Pump Combined with Fingertight UHPLC Nano Column to Boost LC-MS Sensitivity in Proteomics

Parallel LC with Capillary PS-DVB Monolithic Columns for High-Throughput Proteomics

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

Microflow Liquid Chromatography Mass Spectrometry System. Nexera Mikros C146-E350

Expand Your Research with Metabolomics and Proteomics. Christine Miller Omics Market Manager ASMS 2017

H-Class & H-Class Bio AutoBlend and AutoBlend plus. Jean-Michel Plankeele May Waters Corporation 1

A Generic 2D-UPLC/MS Assay for the Identification and Quantification of Host Cell Proteins in Biopharmaceuticals

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona

ION EXCHANGE KIT FOR MAB SEPARATIONS

PESTICIDE SCREENING APPLICATION SOLUTION

Simultaneous in vivo Quantification and Metabolite Identification of Plasma Samples Using High Resolution QTof and Routine MS E Data Analysis

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution

Put the PRO in Protein Characterization

Update to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014

columns PepSwift and ProSwift Capillary Monolithic Reversed-Phase Columns

Separation of Native Monoclonal Antibodies and Identification of Charge Variants:

MassPREP On-Line Desalting Cartridge

Targeted and Untargeted Screening of Microcystins in Lake Water Samples Using High Resolution Mass Spectrometry INTRODUCTION

Mass Detection for the Chromatographer Waters ACQUITY QDa Detector

ApplicationNOTE THE USE OF A NANOLOCKSPRAY ELECTROSPRAY INTERFACE FOR EXACT MASS PROTEOMICS STUDIES

Improved SPE for UPLC/MS Determination of Diquat and Paraquat in Environmental

Quantitative Analysis of pesticides including Phenoxy-acids in surface and drinking water matrices using UPLC-ON-LINE-SPE-MS/MS

timstof Pro with PASEF and Evosep One: Maximizing throughput, robustness and analytical depth for shotgun proteomics

Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins

Faster, easier, flexible proteomics solutions

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Phi29 Scaffold Has a Helix-Loop-Helix Motif and a Disordered Tail. Marc C Morais et al., Nature Structural Biology 2003

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF

Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution

Improving Sensitivity in Bioanalysis using Trap-and-Elute MicroLC-MS

Eoin F.J. Cosgrave, Matthew A. Lauber, Robert Birdsall, and Sean M. McCarthy Waters Corporation, Milford, MA, USA APPLICATION BENEFITS INTRODUCTION

Two-Dimensional LC Protein Separation on Monolithic Columns in a Fully Automated Workflow

Reproducible LC/MS Peptide Separation Using Agilent AdvanceBio Peptide Plus Columns

Transcription:

HDX-MS at Waters 2011 Waters Corporation 1

Hydrogen Deuterium Exchange MS systems Dedicated standards and UPLC BEH separation chemistries nanoacquity UPLC with HDX technology Xevo G2-S QTof MS and Synapt G2-Si HDMS ProteinLynx Global Server (PLGS) and DynamX data processing 2011 Waters Corporation 2

Waters System Solution for Automated HDX nanoacquity UPLC with HDX Automation technology Synapt G2-Si HDMS ProteinLynx Global SERVER (PLGS) DynamX TM Fast chromatography at 0 C Automates HDX experiments Accurate measurement ETD capability Ion mobility Reliable peptic peptide ID by MS E Automated HDX data Processing for deuteration determination 2011 Waters Corporation 3

Waters HDX Workflow at the Peptide Level Relative Deuterium Level (Da) peptide 128-140 12 APO HOLO 10 8 6 4 2 0 0.10 1.00 10.00 100.00 1000.00 Time (min) Undeuterated / H2O Deuterated / D2O Protein in H 2 O, ph 7.40 at room temp Add 20-fold excess D 2 O Protein labeling occurs For various times Quench ph to 2.50, temp to 0 C OPTIONAL AUTOMATION Inside HDX Manager at 0 C Quenched protein is injected into HDX manager at ph 2.5 Local Analysis at Peptide Level Online Pepsin Digestion ph 2.50 nanoacquity UPLC using 1.7 µm BEH130 C18 column for fast separation Peptide map PLGS and IDENTITY E for peptide ID ESI Q - Tof MS E Or ESI HDMS E Deuterium Uptake DynamX Processing Determination 2011 Waters Corporation 4

Measurement of average mass change over time Labeling time 240 m 60 m 100 % 100 0 3.00 4.00 5.00 6.00 7.00 8.00 % 0 3.00 4.00 5.00 6.00 7.00 8.00 100 Uptake of deuterium from 0 solution for different regions 100 vary according to time % % 0 10 m 1 m 100 % 0 3.00 4.00 5.00 6.00 7.00 8.00 100 % 0 3.00 4.00 5.00 6.00 7.00 8.00 100 % 0 100 % 0 Changes in mass (distribution) correlated to conformational changes 100 100 10 s % 0 3.00 4.00 5.00 6.00 7.00 8.00 % 0 0 s 100 % 0 Time 3.00 4.00 5.00 6.00 7.00 8.00 100 % 0 m/z 600 605 610 2011 Waters Corporation 5

Waters M-Class ACQUITY UPLC with HDX Technology Waters next generation UPLC platform for nano to microscale separations True UPLC separations for protein and peptide-level HDX-MS measurements Reproducible, rapid and robust separations at 0 degrees C up to 15K psi 2011 Waters Corporation 6

Complex HDX Data can be Resolved by enabling Ion Mobility Iacob et al; Ion Mobility adds an additional dimension to mass spectrometric analysis of solutionphase hydrogen/ deuterium exchange; Rapid Commun. Mass Spectrom. 2008; 22: 2898 2904 2011 Waters Corporation 7

IMS separates co-eluting labeled peptides UCA064_100901_077_bsa_2m 287 (3.504) Cm (278:306) 100 1: TOF MS ES+ 9.08e4 2 m Labeling No IMS separation % 0 m/z 709 710 711 712 713 714 715 716 717 718 719 Ion Mobility Enabled, p,,, p ( p) UCA064_100901_077_bsa_2m_rt_04_JA2 291 (3.567) Cm (278:294) 1: TOF MS ES+ 100 3.99e4 ASIQKFGERALKA 2+ % 2+ 1+ with IMS-enabled separation 0 m/z 709 710 711 712 713 714 715 716 717 718 719 UCA064_100901_077_bsa_2m_rt_04_JA 284 (3.472) Cm (278:294) 1: TOF MS ES+ 100 3.42e3 % AVEGPKL 1+ 0 m/z 709 710 711 712 713 714 715 716 717 718 719 UCA064 100901 077 b 2 287 (3 504) C (278 306) 1 TOF MS ES 2011 Waters Corporation 8

Ion Mobility Separation No Deuterium Exposure 2011 Waters Corporation 9

Ion Mobility Separation 100 Minute Exposure 2011 Waters Corporation 10

Waters HDX software: DynamX TM Automated uptake calculation Easy view Convenient interpretation 2011 Waters Corporation 11

DynamX: IMS Support 100 min Time Course Changes in Uptake 10 min Peptide Identified Interfering Peptide separated by Mobility 1 min 10 sec Ref 2011 Waters Corporation 12

Understanding the Difference Plot Difference plots represent uptake (Da) differences between ref and exp. A black vertical bar represents a sum of the mass differences observed for each peptide in all time points. Ref (IFN) Confidence limit Black dotted line at y-axis values +1.1 Da Time-course 10 sec 1 min 12 min 60 min 240 min Blue dotted line at y-axis values +0.5 Da Vertical bar Indicates that this peptide showed higher uptake in Oxidized IFN. Exp (Oxidized IFN) What it means These displays are available in DynamX software (except confidence limit). In this data, certain peptides with the significant differences can be easily visualized. In this case, oxidized IFN revealed significant conformational changes in several peptides. Houde, et. al. J. Pharm. Sci. 2011. June 1;100(6):2071-2086 2011 Waters Corporation 13

HDX for Comparability: Experimental Butterfly Chart How different are the two conditions? Butterfly Chart reveals the exchange rate and deuteration incorporation in comparison for all peptides in all time points. APO Where is the peptide #43? Residues 128-140AA, localising the contribution to the difference HOLO 2011 Waters Corporation 15

Leap HDX Automation Manager Independent temperature zones for automated sampling processing HDX manager 2011 Waters Corporation 16

Automated Waters HDX-MS system 2011 Waters Corporation 17

Enzymate Online Digestion Column Pepsin immobilized BEH column, Waters P/N 186007233 2.1 mm X 30 mm 15,000 psi compatibility 2011 Waters Corporation 18

HDX Phos B Check Standard Intact phosphorylase b protein that can be used to evaluate HDX system performance, measure back exchange, and optimize methods P/N 186006930 2011 Waters Corporation 19

HDX/ETD Workflow ETD/HDX can pinpoint conformational changes to a single AA residue ETD presents a practical alternative to fragmentation techniques for high-spatial-resolution HDX studies 2011 Waters Corporation 20

ETD with the SYNAPT G2-Si System Front-end ETD using glow discharge source Compatible with LC separations Permanently mounted Easy operation & maintenance 2011 Waters Corporation 21

ETD/HDX Data can Provide Near AA Residue Spatial Resolution of D Uptake 2011 Waters Corporation 22

Inlet Editor 2011 Waters Corporation 23

Example Inlet Method 2011 Waters Corporation 24

Example Inlet Method Binary Solvent Manager Example gradient is for a 1.0 x 50 mm HSS T3 column. If using a 1.0 x 100 mm BEH column, typical flow rates are 40 to 45 µl/min Fluidic Configuration is set for Single Pump Trapping 2011 Waters Corporation 25

Example Inlet Method Binary Solvent Manager Trapping flow for the BSM should be set to be identical as the initial gradient conditions. Sample loading time (trapping and digestion) is set on this tab. 2011 Waters Corporation 26

Example Inlet Method Auxiliary Solvent Manager The ASM flow rates have been increased to 1000 µl/min. Once software has been released, the ASM will be capable of different flow rates for both analytical and trapping conditions. 2011 Waters Corporation 27

Example Inlet Method HDX Manager The HDX Manager has independent settings for the digestion and chamber temperature. 2011 Waters Corporation 28

Example Inlet Method HDX Manager Data channels must be activated. Errors will occur if they are not. 2011 Waters Corporation 29

Source Conditions 2011 Waters Corporation 30

Instrument 2011 Waters Corporation 31

TriWave 2011 Waters Corporation 32

TriWave DC 2011 Waters Corporation 33

MSe and HDMSe HDMS E Training April 2011 2011 Waters Corporation 34

UPLC/HDMS E deconvoluting chimericy Co-Eluting Peptides Ionized Precursors Precursors IMS Separated Precursors Transferred to TOF MS 2011 Waters Corporation 35

UPLC/HDMS E deconvoluting chimericy Co-Eluting Peptides Ionized Precursors Precursors IMS Separated Precursors & Products Time Aligned 2011 Waters Corporation 36

UPLC/HDMS E Ion mobility 2011 Waters Corporation 37

IMS MS E MS Method Settings 9 100 2000 0.4 2011 Waters Corporation 38

IMS MS E MS Method Settings 4 2 600 2 2 175 20 30 2011 Waters Corporation 39

IMS MS E MS Method Settings 30 Lockspray sampling set to every 30 seconds. 2011 Waters Corporation 40